First Time Loading...

Humanigen Inc
NASDAQ:HGEN

Watchlist Manager
Humanigen Inc Logo
Humanigen Inc
NASDAQ:HGEN
Watchlist
Price: 0.0001 USD Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

HGEN doesn't have a meaningful market cap.

The Relative Value of one HGEN stock under the Base Case scenario is 0.1077 USD. Compared to the current market price of 0.0001 USD, Humanigen Inc is Undervalued by 100%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HGEN Relative Value
Base Case
0.1077 USD
Undervaluation 100%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0
P/S
P/S
Price to Sales
0
vs History
58
vs Industry
97
Median 3Y
21
Median 5Y
2.8
Industry
8.1
Forward
0.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-0.6
Median 5Y
-7.7
Industry
26.2
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-0.6
Median 5Y
-10.3
Industry
22.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-0.6
Median 5Y
-4.8
Industry
21.3
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-0.7
Industry
2.5
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
35
Median 3Y
17.8
Median 5Y
1
Industry
7.3
Forward
-15.4
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.1
More Details
0.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
0.1
vs History
0
vs Industry
28
Median 3Y
-0.6
Median 5Y
-7.5
Industry
4.4
More Details
0.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
0.1
vs History
0
vs Industry
26
Median 3Y
-0.6
Median 5Y
-7.5
Industry
4.3
More Details
0
EV/OCF
EV/OCF
Enterprise Value to OCF
0
vs History
0
vs Industry
29
Median 3Y
-0.5
Median 5Y
-10
Industry
5.4
More Details
0
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
0
vs History
0
vs Industry
25
Median 3Y
-0.5
Median 5Y
-10
Industry
3.2
More Details
0.1
EV/IC
EV/IC
Enterprise Value to IC
0.1
vs History
0
vs Industry
72
Median 3Y
-0.9
Median 5Y
-39.3
Industry
5
More Details

Multiples Across Competitors

HGEN Competitors Multiples
Humanigen Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Humanigen Inc
NASDAQ:HGEN
23.8k USD 0 -0 0.1 0.1
US
Abbvie Inc
NYSE:ABBV
287.1B USD 5.3 60 12.9 19.7
US
Amgen Inc
NASDAQ:AMGN
168.4B USD 6 25.1 18 27
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
103.5B USD 7.9 26.2 17.6 19.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.4B USD 10.5 28.6 22.8 23.9
AU
CSL Ltd
ASX:CSL
133.2B AUD 6.2 35.6 21.6 26.7
US
Gilead Sciences Inc
NASDAQ:GILD
80.3B USD 2.9 166 6.7 8.7
US
Moderna Inc
NASDAQ:MRNA
46.9B USD 6.9 -10 -10.8 -9.2
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.5B USD 3.3 27 13.8 17.3
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6
P/E Multiple
Earnings Growth
US
Humanigen Inc
NASDAQ:HGEN
Average P/E: 55.2
Negative Multiple: -0 		N/A
US
Abbvie Inc
NYSE:ABBV
60
405%
US
Amgen Inc
NASDAQ:AMGN
25.1
82%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
26.2
46%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.6
49%
AU
CSL Ltd
ASX:CSL
35.6
84%
US
Gilead Sciences Inc
NASDAQ:GILD
166
75%
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -10 N/A
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -57.5 N/A
US
Biogen Inc
NASDAQ:BIIB
27
154%
KR
Celltrion Inc
KRX:068270
73.1
105%

See Also

Summary
HGEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
HGEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HGEN stock valuation using valuation multiples.
Wall Street Estimates
HGEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HGEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.